anti-Human pro-Brain Natriuretic Peptide, N-terminal (NT-proBNP) (a.a. 13-27) Monoclonal Antibody

Product Notes

The pro-Brain Natriuretic Peptide, N-terminal (NT-proBNP) (a.a. 13-27) (Catalog #AAA312447) is an Antibody produced from Host: Mouse. Hybridization of Sp2/0 myeloma cells with spleen cells from Balb/c mice. Source: Ascites and is intended for research purposes only. The product is available for immediate purchase. The MAb to proBNP, N-terminal reacts with Human and may cross-react with other species as described in the data sheet. AAA Biotech's pro-Brain Natriuretic Peptide, N-terminal (NT-proBNP) (a.a. 13-27) can be used in a range of immunoassay formats including, but not limited to, Immunoassay Antibody Pairs, Western Blot. NT-proBNP and proBNP immunoassay. Works in Western blot. Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessarily be excluded.Precautions All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.

Disclaimer

Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.